Participants 34 102 9
fails to modify motor symptoms in patients with Parkinson's disease.
Participants 242 289 10
two groups of patients with Parkinson's disease
Participants 291 517 15
The first group was composed of 10 patients with a moderate motor impairment insufficiently controlled by monotherapy with bromocriptine. The second group was composed of eight patients with L-dopa-induced peak-dose dyskinesia
